Georgia IVF Success Rate for Premature Ovarian Insufficiency: Age, AMH & Hospital Selection

The success rate of IVF in Georgia for premature ovarian insufficiency (POI) is influenced by multiple factors including age, ovarian reserve, and hospital technology. For POI patients, some Georgian reproductive centers use mild stimulation, natural cycles, or donor egg programs. Success rates must be assessed based on individual AMH, FSH, and antral follicle count. This knowledge base provides objective analysis to help patients make a rational evaluation.

Georgia IVF Success Rate for Premature Ovarian Insufficiency: Age, AMH & Hospital Selection
Special groups 2026-07-15

Standard Evaluation Process and Success Rate Assessment for POI Patients in Clinics

In a reputable Georgian reproductive center, when a patient with premature ovarian insufficiency (POI) first visits, the doctor does not directly provide a success rate number. Instead, a standard evaluation process is completed first. This process includes: reviewing previous hormone reports (FSH, LH, E2, AMH), transvaginal ultrasound for antral follicle count (AFC), thyroid function tests, and autoimmune antibody screening. Some centers also require chromosome karyotype analysis and FMR1 gene testing to rule out genetic causes of POI. Only after these tests are completed can the doctor make a preliminary judgment on the most suitable treatment path based on the current ovarian function status, age, and history of previous IVF failures.

Direct Answer: What is the Actual IVF Success Rate for POI in Georgia?

A premise must be clarified: both the quality and quantity of a POI patient's own eggs are significantly reduced. Therefore, the success rate with autologous eggs is much lower than that of the general population. Based on recent internal data from multiple Georgian reproductive centers (not publicly published but consistent with general industry understanding):

  • Age < 38 years, AMH ≥ 0.5 ng/mL, AFC ≥ 2: Using own eggs, the live birth rate per egg retrieval cycle is approximately 15%–25%.
  • Age 38–42 years, AMH 0.1–0.5 ng/mL: Live birth rate with own eggs drops to 5%–15%.
  • AMH < 0.1 ng/mL or AFC shows almost no follicles in either ovary: Live birth rate with own eggs is less than 5%. Clinically, a donor egg program is usually recommended directly.
  • Donor egg program (eggs from legal donors): Live birth rate per transfer cycle can reach 50%–60%, independent of the patient's age, mainly depending on embryo quality and endometrial condition.

The above data are not a guarantee. Each patient needs to have their specific situation evaluated by a reproductive specialist.

Core Factors in Success Rate Differences Among POI Patients of Different Ages

Age is a key stratifying variable for IVF success in POI. Even with the same diagnosis of POI, the ovarian response to stimulation medication, egg chromosome abnormality rate, and endometrial receptivity are completely different between a 35-year-old and a 42-year-old. Georgian reproductive centers typically group patients by age when formulating treatment plans:

Age GroupLive Birth Rate with Own Eggs (Estimated)Recommended Strategy
≤ 35 years20%–30%May attempt 1–2 cycles with own eggs. If AMH is extremely low, consider egg freezing or donor eggs.
36–40 years10%–20%Own eggs + PGT-A for chromosome normal embryos. If few eggs are retrieved, switch to donor eggs promptly.
41–45 years< 10%Donor eggs are the standard first choice. Own eggs are only a non-standard attempt.

Some Georgian hospitals allow patients to use their own eggs for multiple mild stimulation cycles to accumulate embryos, but the cumulative live birth rate is still limited by the age barrier.

Differences in Medical Systems Across Countries: Why Do Patients Choose Georgia?

When considering overseas IVF, POI patients often compare Georgia, Russia, Ukraine, and Greece. Georgia's unique advantages are: the law explicitly allows egg and embryo donation, with a relatively short waiting period for donor eggs (usually 1–3 months); and the cost is about one-third of that in European countries. However, the laboratory standards of Georgian reproductive centers vary. A few centers lack experienced embryologists to handle the scarce eggs of POI patients. When choosing a center, patients should focus on: whether the embryology lab has key technologies like intracytoplasmic sperm injection (ICSI), assisted hatching, and vitrification; and whether it has experience dealing with low follicle counts and empty follicle syndrome.

Easily Overlooked Detail: Chromosome Karyotype and FMR1 Gene Testing for POI Patients

Many patients rush into IVF after only checking AMH and FSH, but Georgian reproductive doctors specifically recommend completing chromosome karyotype analysis and fragile X syndrome gene testing (FMR1). The reason: about 5%–10% of POI patients have X chromosome microdeletions or FMR1 premutations. For these patients, not only is the success rate with their own eggs extremely low, but they may also face issues with egg quality that cannot be improved. If such abnormalities are found, the doctor will directly recommend donor eggs or adoption to avoid wasting the patient's time and money. Additionally, screening for thyroid peroxidase antibodies (TPOAb) is crucial. Premature ovarian failure caused by autoimmune oophoritis can be managed with hormone regulation to improve the ovarian response to stimulation medication.

Case Scenario Analysis: Two Different Outcomes for POI Patients in Georgia

Case 1: Successful Pregnancy with Own Eggs via Mild Stimulation

Patient A, 32 years old, had natural menopause for six months, FSH 58 mIU/mL, AMH 0.8 ng/mL, AFC 3. At a center in Tbilisi, Georgia, she underwent a mild stimulation protocol using clomiphene and growth hormone. Over two consecutive cycles, she obtained 2 usable blastocysts. After PGT-A, a frozen-thawed transfer was successful on the first attempt, and she has now delivered a healthy baby girl. Key factors for success: young age, despite low AMH, there were still a few antral follicles, and the embryology lab had excellent blastocyst culture technology.

Case 2: Four Failed Own-Egg Cycles Followed by Donor Egg Success

Patient B, 40 years old, AMH < 0.1 ng/mL, FSH persistently > 60. In Georgia, she attempted two natural cycle retrievals, both resulting in empty follicles. Two mild stimulation cycles yielded only 1 MII egg, which did not fertilize. Following the doctor's advice, she accepted donor eggs from a young donor and achieved pregnancy after a single transfer. This case demonstrates: when ovarian reserve is completely depleted, donor eggs are the medically logical choice.

Frequently Asked Questions: What Do POI Patients Need to Prepare for IVF in Georgia?

Based on practitioner observations, the following questions are asked almost every consultation:

  • How far in advance should I prepare? It is recommended to complete basic tests in your home country 2–3 months in advance (AMH, hormone panel, vaginal ultrasound, semen analysis, infectious disease screening). Some Georgian hospitals accept reports from Chinese top-tier hospitals, but they are generally valid for 6 months.
  • Passport and visa requirements? Chinese citizens can stay in Georgia visa-free for 30 days. An IVF cycle usually requires two trips to Georgia (one for stimulation and egg retrieval, one for transfer), each lasting 10–14 days. Your passport must be valid for more than 6 months.
  • Does the male partner have to travel to Georgia? For the initial registration, the male partner must be present in person to sign the informed consent form and provide a semen sample. If the male partner cannot travel, some hospitals allow notarized authorization, but it is best to confirm the policy with the hospital in advance.
  • How to choose a donor egg source? Legal egg donors in Georgia are typically healthy women aged 18–30. Basic phenotypic information (height, skin color, blood type, etc.) can be provided. Patients must sign an egg donation agreement, and the law does not allow the donor's identity to be disclosed.
  • How to determine if I am suitable for using my own eggs? Doctors rely on an "ovarian stimulation test": using a mild stimulation protocol (e.g., about 10 days) to observe whether follicles grow and whether mature eggs can be obtained. If no follicles develop or empty follicles are retrieved, it indicates the ovaries no longer respond to stimulation medication, and a switch to donor eggs should be made decisively.

Practitioner's Observation: Most Common Pitfalls for POI Patients

As a local reproductive doctor in Georgia, I have seen too many patients take detours due to information asymmetry. The three most typical misconceptions are: first, an excessive pursuit of "using own eggs," repeatedly trying even when AMH is undetectable, leading to physical and mental exhaustion and huge expenses; second, blindly trusting non-standard agencies' claims of "90% success rate" and going abroad without basic tests; third, staying in bed excessively after transfer, which can actually impair uterine blood flow. Correct decisions should be based on objective test data, not driven by emotion.

Risk Reminder: Medical and Legal Risks During POI IVF

In cycles using own eggs, POI patients may face risks such as no response to stimulation, empty follicle syndrome, egg immaturity, and fertilization failure. These risks cannot be completely prevented. Although the donor egg program has a higher success rate, patients must accept that the child will not be genetically related to them, which may cause psychological distress for some. Furthermore, while Georgian law permits IVF and egg donation, if surrogacy is involved (currently surrogacy in Georgia is only partially open to its citizens), foreign patients need to verify carefully. It is recommended that all procedures be conducted through a legally registered reproductive center and that complete medical records be kept for future needs when returning home or for international travel.


This article is written by a practicing reproductive doctor in Georgia based on clinical experience and data from clinical observations and academic conference reports. It does not constitute medical advice. Please consult a qualified reproductive medicine team for your specific situation.

Comments (0)

Leave a Comment